宁泌泰胶囊治疗慢性前列腺炎的疗效观察

目的探讨宁泌泰胶囊治疗慢性前列腺炎的临床疗效。方法290例慢性前列腺炎患者随机分成2组。对照组140例，采用左氧氟沙星0.4g或阿奇霉素0.5g，1次／d，静脉滴注，2周后改用左氧氟沙星0.2g或阿奇霉素0.25g，口服，2次／d，服用吲哚美辛25rag／次，1次／d。治疗组150例，除与对照组上述治疗相同外，加用宁泌泰胶囊2片／次，3次／d；4周为一个疗程，治疗2个疗程。随访3-6个月，详细记录治疗过程中的症状、体征、EPS常规和尿常规。结果治疗组治愈85例（56.7％），显效40例（26.7％）；有5例临床症状、体征明显减轻，NIH-CPSI降低50％以上，但EPS：由治疗前WBC〉10个／HP上升至WBC60个／HP，总有效125例（总有效率83.3％），无效25例（16.7％）；对照组140例，其中治愈65例（46.4％），显效30例（21.4％），在对照组有10例治疗前EPS：WBC〉10个／HP，而治疗后无改变，但临床症状、体征明显减轻，NIH-CPSI降低50％以上，也列为显效，总有效95例（总有效率67.9％），无效45例（32.1％）。2组比较差异有统计学意义（P〈0.05）。结论宁泌泰胶囊治疗慢性前列腺炎有较满意的临床疗效。

The clinical efficacy of Ningmitai capsule on chronic prostatitis

Objective To evaluate the efficacy of Nimitai capsule in the treatment of chronic prostatitis. Methods 290 cases of chronic prostatitis were treated, who were divided randomly into the treatment group and control group. 150 cases of the treatment group was treated by Ningmitai capsule and routine antibacterial drugs,while 140 cases of the control group only by routine antibacterial drugs. Routine treatment was carried out 8 week in all the 290 cases. Results In the treatment group the curative rate was 56.67%, the remarkable effective rate was 26.67% , and the total effective rate was 83.34%. Meanwhile in the control group, it was 46.43% ,21.43% and 67.86% respectively. There was significant difference between the two groups （P〈0.05）Conclusions Ningmitai capsule has a better efficacy on choronic prostatitis.